Volker H. Hackert
Heerlen, LI 6400AA, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Four million COVID-19 cases in four European cross-border regions reveal minimal cross-border transmission effect on domestic burden: space-time cluster analysis.
Journal: BMC infectious diseases
Published: September 06, 2024
Impact of a large-scale event on SARS-CoV-2 cases and hospitalizations in the Netherlands, carnival seasons 2022 and 2023.
Journal: Public health in practice (Oxford, England)
Published: January 20, 2024
SARS-CoV-2 transmission dynamics in bars, restaurants, and nightclubs.
Journal: Frontiers in microbiology
Published: March 10, 2023
Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type.
Journal: Frontiers in microbiology
Published: August 24, 2022
Increased transmissibility of SARS-CoV-2 alpha variant (B.1.1.7) in children: three large primary school outbreaks revealed by whole genome sequencing in the Netherlands.
Journal: BMC infectious diseases
Published: November 23, 2021
Linked nosocomial COVID-19 outbreak in three facilities for people with intellectual and developmental disabilities due to SARS-CoV-2 variant B.1.1.519 with spike mutation T478K in the Netherlands.
Journal: BMC infectious diseases
Published: June 03, 2021
COVID-19: first long-term care facility outbreak in the Netherlands following cross-border introduction from Germany, March 2020.
Journal: BMC infectious diseases
Published: August 28, 2020
Signs and symptoms do not predict, but may help rule out acute Q fever in favour of other respiratory tract infections, and reduce antibiotics overuse in primary care.
Journal: BMC infectious diseases
Published: March 23, 2020
Q fever: Evidence of a massive yet undetected cross-border outbreak, with ongoing risk of extra mortality, in a Dutch-German border region.
Journal: Transboundary and emerging diseases
Published: July 12, 2019
The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.
Journal: Vaccine
Published: April 24, 2018
Last Updated: 09/26/2026